News Column

Analyst Moves: ZNGA, PFE, GILD

February 4, 2014

This morning, UBS upgraded shares of Zynga (ZNGA) from neutral to buy as core operations are beginning to stabilize and cost cutting efforts are taking hold. In the report, UBS set a price target of $6. Shares of Zynga were higher on the news, gaining 3.3% so far. Jefferies upgraded shares of Pfizer (PFE) from hold to buy as management's restructuring efforts are increasing efficiencies. In the report, Jefferies set a $38 price target. Shares of Pfizer were higher by 2.4% on Tuesday. And Robert Baird upgraded shares of Gilead (GILD) from neutral to outperform as the company is seeing stronger sales from its product pipeline. In report, Robert Baird set a $103 price target. Shares of Gilead were higher by 3.4% this afternoon. The preceding is a transcript of the video published at: .

For more stories on investments and markets, please see HispanicBusiness' Finance Channel


Story Tools